NCT04039529 is a NA clinical trial of SCENERGY-guided Biopsy in Liver Biopsy, sponsored by Clear Guide Medical.

Who is sponsoring NCT04039529?

NCT04039529 is sponsored by Clear Guide Medical.

What drugs are being tested in NCT04039529?

Interventions in NCT04039529: SCENERGY-guided Biopsy.

What condition does NCT04039529 study?

NCT04039529 studies Liver Biopsy, Lung Biopsy, Kidney Biopsy.

Is NCT04039529 still recruiting?

NCT04039529 is currently withdrawn. Last updated 9 February 2023.

Last reviewed 2023-02-09 · How we verify

NCT04039529

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Novel Guidance Device for Image Fusion and Needle Guidance in Lung, Liver or Kidney Biopsy

Withdrawn NA Last updated 9 February 2023

What this trial tests

NA trial testing SCENERGY-guided Biopsy in Liver Biopsy. Withdrawn.

Timeline

31 December 2019

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Clear Guide Medical
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Start date	31 December 2019
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across United States

Drugs / interventions tested

SCENERGY-guided Biopsy

Conditions studied

Liver Biopsy — all drugs for Liver Biopsy →
Lung Biopsy — all drugs for Lung Biopsy →
Kidney Biopsy — all drugs for Kidney Biopsy →

Sponsor

Clear Guide Medical

Who can join

Adults 18 to 80, any sex, with Liver Biopsy or Lung Biopsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates whether a new image fusion technology can reduce patient radiation dose from CTs and/or procedure time during biopsies of lung, liver or kidney.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Clear Guide Medical trials

Trials by the same sponsor.

NCT04039490 — Novel Device for Ultrasound-guided Pediatric Vessel Cannulations · NA · recruiting
NCT05889923 — Training and Evaluation of Ultrasound-Guided Procedures · NA · completed
NCT04031495 — Image Guidance for Improved Vessel Cannulation in Pediatric Patients · NA · completed
NCT03226535 — Ultrasound-CT Fusion System for Interventional Radiology Procedures · NA · unknown
NCT02614222 — Computer Assisted Instrument Guidance (CAIG) for Orthopedic Peripheral Nerve Blocks · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04039529 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Clear Guide Medical
Last refreshed: 9 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04039529.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing